These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29453529)

  • 41. In vitro evaluation of cellular response induced by manufactured nanoparticles.
    Horie M; Kato H; Fujita K; Endoh S; Iwahashi H
    Chem Res Toxicol; 2012 Mar; 25(3):605-19. PubMed ID: 22136515
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Health impact and toxicological effects of nanomaterials in the lung.
    Kendall M; Holgate S
    Respirology; 2012 Jul; 17(5):743-58. PubMed ID: 22449246
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Toxicology of nanoparticles.
    Elsaesser A; Howard CV
    Adv Drug Deliv Rev; 2012 Feb; 64(2):129-37. PubMed ID: 21925220
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Compilation of Data and Modelling of Nanoparticle Interactions and Toxicity in the NanoPUZZLES Project.
    Richarz AN; Avramopoulos A; Benfenati E; Gajewicz A; Golbamaki Bakhtyari N; Leonis G; Marchese Robinson RL; Papadopoulos MG; Cronin MT; Puzyn T
    Adv Exp Med Biol; 2017; 947():303-324. PubMed ID: 28168672
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methodological considerations when conducting in vitro, air-liquid interface exposures to engineered nanoparticle aerosols.
    Secondo LE; Liu NJ; Lewinski NA
    Crit Rev Toxicol; 2017 Mar; 47(3):225-262. PubMed ID: 27648750
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Engineered nanoparticles induced brush border disruption in a human model of the intestinal epithelium.
    Faust JJ; Masserano BM; Mielke AH; Abraham A; Capco DG
    Adv Exp Med Biol; 2014; 811():55-72. PubMed ID: 24683027
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Artemia salina as a model organism in toxicity assessment of nanoparticles.
    Rajabi S; Ramazani A; Hamidi M; Naji T
    Daru; 2015 Feb; 23(1):20. PubMed ID: 25888940
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nanoparticle-induced pulmonary toxicity.
    Li JJ; Muralikrishnan S; Ng CT; Yung LY; Bay BH
    Exp Biol Med (Maywood); 2010 Sep; 235(9):1025-33. PubMed ID: 20719818
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toxicological properties of nanomaterials.
    Zhang M; Jin J; Chang YN; Chang X; Xing G
    J Nanosci Nanotechnol; 2014 Jan; 14(1):717-29. PubMed ID: 24730292
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies.
    Khlebtsov N; Dykman L
    Chem Soc Rev; 2011 Mar; 40(3):1647-71. PubMed ID: 21082078
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation.
    Kunzmann A; Andersson B; Thurnherr T; Krug H; Scheynius A; Fadeel B
    Biochim Biophys Acta; 2011 Mar; 1810(3):361-73. PubMed ID: 20435096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analytical methods to assess nanoparticle toxicity.
    Marquis BJ; Love SA; Braun KL; Haynes CL
    Analyst; 2009 Mar; 134(3):425-39. PubMed ID: 19238274
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Particles in the oceans: Implication for a safe marine environment.
    Blasco J; Corsi I; Matranga V
    Mar Environ Res; 2015 Oct; 111():1-4. PubMed ID: 26515473
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Understanding nanoparticle cellular entry: A physicochemical perspective.
    Beddoes CM; Case CP; Briscoe WH
    Adv Colloid Interface Sci; 2015 Apr; 218():48-68. PubMed ID: 25708746
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A fruit fly in the nanoworld: once again Drosophila contributes to environment and human health.
    Vecchio G
    Nanotoxicology; 2015 Mar; 9(2):135-7. PubMed ID: 24766263
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Toxicological Considerations, Toxicity Assessment, and Risk Management of Inhaled Nanoparticles.
    Bakand S; Hayes A
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27314324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Toxicologic Concerns with Current Medical Nanoparticles.
    Cheng TM; Chu HY; Huang HM; Li ZL; Chen CY; Shih YJ; Whang-Peng J; Cheng RH; Mo JK; Lin HY; Wang K
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nanotoxicity: the growing need for in vivo study.
    Fischer HC; Chan WC
    Curr Opin Biotechnol; 2007 Dec; 18(6):565-71. PubMed ID: 18160274
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nanotoxicity of Inert Materials: The Case of Gold, Silver and Iron.
    Umair M; Javed I; Rehman M; Madni A; Javeed A; Ghafoor A; Ashraf M
    J Pharm Pharm Sci; 2016; 19(2):161-80. PubMed ID: 27518167
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Applying quantitative structure-activity relationship approaches to nanotoxicology: current status and future potential.
    Winkler DA; Mombelli E; Pietroiusti A; Tran L; Worth A; Fadeel B; McCall MJ
    Toxicology; 2013 Nov; 313(1):15-23. PubMed ID: 23165187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.